Skip to main content
Premium Trial:

Request an Annual Quote

Steven Beasley, Steve Kushman, Mark Atlas, Andrey Zarur, John Steuart

Premium
Gentronix last week said it had appointed Steven Beasley as commercial director and member of the board.
 
Beasley will head the commercial operations of Gentronix as it moves forward with its growth plans for GreenScreen HC and its next-generation products. He was previously CEO of bioKneX and chief business officer of De Novo Pharmaceuticals.
 

 
Fluxion said last week that it has hired Steve Kushman as manufacturing director and Mark Atlas as sales director. The company also announced that Andrey Zarur, a general partner of Kodiak Venture Partners, and John Steuart, a co-founder and managing director of Claremont Creek Ventures, will join its board of directors (see story, this issue).

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.